Company Valuation: Alamar Biosciences, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2026 2027 2028
Market Cap 1 2,130 - -
Change - - -
Enterprise Value (EV) 1 2,041 2,072 2,102
Change - 1.55% 1.46%
P/E -25.2x -44.4x -86.6x
PBR 5.57x 7.8x 7.89x
PEG 0.3x 1x 1.8x
Capitalization / Revenue 18x 12.9x 9.5x
EV / Revenue 17.2x 12.5x 9.38x
EV / EBITDA -37.5x -44.1x -215x
EV / EBIT -34.6x -39.2x -139x
EV / FCF -23.5x -42.4x -101x
FCF Yield -4.26% -2.36% -0.99%
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -1.216 -0.6916 -0.3542
Distribution rate - - -
Net sales 1 118.6 165.7 224.2
EBITDA 1 -54.4 -47.02 -9.78
EBIT 1 -58.98 -52.82 -15.1
Net income 1 -64.93 -49.81 -25.31
Net Debt 1 -89.09 -57.53 -27.23
Reference price 2 30.69 30.69 30.69
Nbr of stocks (in thousands) 69,393 - -
Announcement Date - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-25.23x17.21x-37.51x - 2.13B
34.53x5.85x22.47x0.28% 249B
36.99x6.96x21.81x0.63% 162B
51.68x12.65x27.12x-.--% 157B
17.34x3.44x11.18x-.--% 66.22B
49.46x12.26x27.02x-.--% 52.3B
20.5x2.46x12.41x2.46% 52.18B
35.31x7.06x22.39x-.--% 51.34B
33.72x6.68x22.73x0.59% 48.79B
79.42x7.56x22.95x-.--% 44.57B
Average 33.37x 8.21x 15.26x 0.44% 88.56B
Weighted average by Cap. 38.90x 7.48x 21.90x 0.37%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Alamar Biosciences, Inc.

Historical PBR trend

Valuation ratios - PBR - Alamar Biosciences, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Alamar Biosciences, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Alamar Biosciences, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Alamar Biosciences, Inc.
  1. Stock Market
  2. Stocks
  3. ALMR Stock
  4. Valuation Alamar Biosciences, Inc.